Ilievski Vladimir, Lu Shi-Jiang, Hirsch Emmet
Department of Obstetrics and Gynecology, Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA.
Reprod Sci. 2007 May;14(4):315-20. doi: 10.1177/1933719107302959.
The objective of this study is to test whether the activation of toll-like receptors (TLRs) 2 and 3 (innate immune receptors for gram-positive and viral pathogens, respectively) can induce preterm delivery. One uterine horn of preterm pregnant CD-1 mice at approximately 75% of gestation was injected with TLR-2 ligands (lipoteichoic acid [LTA] or peptidoglycan [PGN]) or the TLR-3 ligand polyinosinic:cytidylic acid (poly[I:C]). Preterm delivery was recorded. In a separate group of mice, tissue mRNAs were quantified by reverse transcriptase polymerase chain reaction 5 hours after treatment with PGN or poly(I:C). Intrauterine PGN and LTA induced preterm delivery, reaching 100% at maximal doses. Intraperitoneal PGN also induced preterm delivery but at lower rates (maximum = 55%). Intrauterine poly(I:C) induced preterm birth in up to 31% of mice. Poly(I:C) induced uterine interferon beta and chemokine (C-C motif) ligand 5 (CCL5, also known as RANTES) but not interleukin 1beta, tumor necrosis factor, or lipopolysaccharide-induced CXC chemokine. PGN did not alter these mRNAs when compared with saline. Neither treatment induced gene expression in fetal membranes. Activation of either TLR-2 or -3 can induce preterm delivery in the mouse. Activation of TLR-3 with poly(I:C) induces interferon beta and the chemokine CCL5 in uterine tissues but not in fetal membranes.
本研究的目的是测试Toll样受体(TLR)2和3(分别为革兰氏阳性菌和病毒病原体的天然免疫受体)的激活是否会诱导早产。在妊娠约75%时,给早产的CD-1小鼠的一个子宫角注射TLR-2配体(脂磷壁酸 [LTA] 或肽聚糖 [PGN])或TLR-3配体聚肌苷酸:胞苷酸(聚 [I:C])。记录早产情况。在另一组小鼠中,用PGN或聚(I:C)处理5小时后,通过逆转录聚合酶链反应对组织mRNA进行定量。宫内注射PGN和LTA可诱导早产(最大剂量时达到100%)。腹腔注射PGN也可诱导早产,但发生率较低(最高为55%)。宫内注射聚(I:C)可使高达31%的小鼠早产。聚(I:C)可诱导子宫产生干扰素β和趋化因子(C-C基序)配体5(CCL5,也称为调节激活正常T细胞表达和分泌因子),但不诱导白细胞介素1β、肿瘤坏死因子或脂多糖诱导的CXC趋化因子。与生理盐水相比,PGN不会改变这些mRNA。两种处理均未诱导胎膜中的基因表达。激活TLR-2或-3均可诱导小鼠早产。用聚(I:C)激活TLR-3可在子宫组织而非胎膜中诱导干扰素β和趋化因子CCL5。